ArticleUrology research & practice2026
The Effect of Intravesical Bacillus Calmette-Guerin Treatment on Sexual Functions and Mental Health in Male and Female Patients Diagnosed with Non-Muscle Invasive Bladder Cancer.
Article in Urology research & practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThe aim of this study is to investigate the effect of intravesical Bacillus Calmette-Guerin (BCG) treatment on sexual functions in females and males diagnosed with non-muscle invasive bladder cancer (NMIBC).
methodsThe study included 87 patients, who presented to the authors' clinic, were diagnosed with NMIBC, and underwent intravesical BCG immunotherapy. All participants were interviewed thrice: before the first dose, after the third dose, and 4 weeks after the sixth dose of BCG. The Demographic Information Form, the Beck Depression Inventory (BDI), the International Index of Erectile Function (IIEF-5) (in males), and the Female Sexual Function Index (FSFI) (in females) were used in all 3 sessions.
resultsBeck Depression Inventory scores of both males (4.74 ± 4.47, 10.22 ± 6.98, and 5.78 ± 4.96, respectively) and females (9.11 ± 5.33, 15.06 ± 5.3, and 9.67 ± 6.61) significantly increased after the third dose but decreased 4 weeks after the sixth dose of BCG (P < .001). In addition, it was observed that the IIEF-5 scores for males (19.7 ± 6.3, 8.24 ± 8.03, and 17.9 ± 7.11, respectively) and the FSFI scores for females (13.03 ± 8.47, 4.83 ± 6.28, and 11.66 ± 9.04 respectively) decreased after the third dose but increased 4 weeks after the sixth dose of BCG (P < .001).
conclusionRepeated intravesical BCG treatments for patients with NMIBC may lead to sexual dysfunction (SD) and mental health. In this study, the peak SD was observed during the treatment process among male and female patients diagnosed with NMIBC who initiated a 6-week BCG treatment. In addition, both men and women were found to be mildly depressed during treatment. These findings tended to improve approximately 4 weeks after the end of the treatment. Cite this article as: Kettas Dolek E, Biyikoglu M, Cayan S, Senel S, Bozlu M, Akbay E. The effect of intravesical Bacillus Calmette- Guerin treatment on sexual functions and mental health in male and female patients diagnosed with non-muscle invasive bladder cancer. Urol Res Pract. 2026, 52, 0045, doi: 10.5152/tud.2026.25045.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.